Over the past two decades, eosinophilic esophagitis (EoE) has emerged as a leading cause of dysphagia and foregut symptoms in children and adults around the world. The 2021 Freston Conference, Sept. 18-19, will explore the impact of EoE and other EGIDs on inflammatory bowel disease (IBD), irritable bowel disease (IBS) and non-ulcer dyspepsia and review strategies to use in patient care. Register by Sept. 10 and save up to $100.
Join us and acquire a deep understanding about the role of:
- Epithelial barrier dysfunction.
- Mast cell interactions,
- Food allergies.
The 2021 Freston Conference will also provide opportunities to network with GI physicians employing care strategies to support their patients with EGIDs and researchers knowledgeable of the clinical trials and studies. Equip yourself with information to mitigate EGID-related conditions.